AUSTIN, Texas, March 25 (Reuters) - Representatives of
Johnson & Johnson and the state of Texas will head back to court
on Tuesday over a $158 million settlement agreement announced in
January involving the drug Risperdal, a spokesman for Texas
Attorney General Greg Abbott said on Sunday.
No comments:
Post a Comment